TMO on XNYS, Technology, Thermo Fisher Scientific, Inc., job postings
Measures activity, not value. Not investment advice.
Shares rose 49% in six months as quarterly revenue grew 9.1% to $12.1B.
GoodInstitutional holders rose 7.9% to 2,772 in the latest quarter
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 26 Sep 2026
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
expected around 28 Jan 2027 (an estimate: a year ago it reported on 29 Jan 2026)
Revenue and net income per quarter. Quarter to 26 Sep 2026: revenue $12.1B, net income $1.7B.
31 Dec 2021RevenueNet incometallest bar $12.2B26 Sep 2026
See the numbers
Quarter to
Revenue
Net income
26 Sep 2026
$12.1B
$1.7B
27 Jun 2026
$12.0B
$1.7B
28 Mar 2026
$11.0B
$1.7B
31 Dec 2025
$12.2B
$2.0B
27 Sep 2025
$11.1B
$1.6B
28 Jun 2025
$10.9B
$1.6B
29 Mar 2025
$10.4B
$1.5B
31 Dec 2024
$11.4B
$1.8B
28 Sep 2024
$10.6B
$1.6B
29 Jun 2024
$10.5B
$1.6B
30 Mar 2024
$10.3B
$1.3B
31 Dec 2023
$10.9B
$1.6B
30 Sep 2023
$10.6B
$1.7B
1 Jul 2023
$10.7B
$1.4B
1 Apr 2023
$10.7B
$1.3B
31 Dec 2022
$11.4B
$1.6B
1 Oct 2022
$10.7B
$1.5B
2 Jul 2022
$11.0B
$1.7B
2 Apr 2022
$11.8B
$2.2B
31 Dec 2021
$10.7B
$1.7B
Fundamentals, 12 months to 26 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$47.4B
$43.7B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+8.3%
+7.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$7.1B
$6.6B
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$18.96
$17.31
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
49.0%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
17.9%
17.2%
6.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
14.9%
15.0%
-0.7%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
13.4%
1.6%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$7.6B
$6.1B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$6.1B
$3.5B
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$41.4B
$35.7B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$35.3B
$32.1B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.76
0.42
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$147.80
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
35.1
29.4
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
5.2
3.7
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
6.0
4.7
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
4.5
2.7
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
0.26%
0.82%
Latest = 12 months to 26 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$20.2M
bought $0, sold $20.2M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+7.9%
2,772 13F filers vs 2,570
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
91%
336.5M shares held by 13F filers (30 Sep 2026) of 370.5M outstanding (26 Sep 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
1.3%
4.8M shares sold short (30 Oct 2026) of 370.5M outstanding (26 Sep 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
2.0
4.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-2.1%
4.9M shares sold short in the report before, 4.8M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
51%
51% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
3,263
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-35%
174 vs 267 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+9.1%
$12.1B vs $11.1B (quarter ended 26 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+8.2%
$437.0M vs $404.0M (quarter ended 26 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$87.1M
the 12 months before: $110.9M
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$2.0M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
118
the 12 months before: 300
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
55
55 articles in the last 7 days; its usual week has 8 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.9×
55 articles in the last 7 days; its usual week has 8.
Unusual now sharp changes in the last 90 days, compared with its own past
New institutional positions 309, 1.6× a year earlier
Visa applications 17, -67% vs a year earlier
New agency award $2.3M, first
Price $669.54 on 20 Nov 2026, +17% over 12 months (12-month range $438.34 to $721.63)
Sharp change
8-K and other filings
WARN layoff notice
Federal award
Lobbying filing
Insider net buying (open market). Insiders sold a net $131.5M in the last 12 months (the 12 months before: -$90.2M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 174 published in the last 12 months, -35% on the 12 months before.Revenue per quarter. Revenue $12.1B in the latest quarter, +9.1% on a year earlier.Capital spending per quarter. Capital spending $437.0M in the latest quarter, +8.2% on a year earlier.Institutional holders (13F filers). 2,772 13F filers reported holding it in the latest 13F quarter, +16% on a year earlier.Federal obligations. Federal obligations: $104.6M published in the last 12 months, -5.6% on the 12 months before.Lobbying spend. Lobbying spend: $2.0M published in the last 12 months, -25% on the 12 months before.Workers in WARN layoff notices. Workers in WARN layoff notices: 118 published in the last 12 months, -61% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source.
Quarter ended 31 Dec 2021: $10.7B, +1.4% on a year earlier; public on 25 Feb 2022
Quarter ended 2 Apr 2022: $11.8B, +19% on a year earlier; public on 7 May 2022
Quarter ended 2 Jul 2022: $11.0B, +18% on a year earlier; public on 6 Aug 2022
Quarter ended 1 Oct 2022: $10.7B, +14% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $11.4B, +7.0% on a year earlier; public on 24 Feb 2023
Quarter ended 1 Apr 2023: $10.7B, -9.4% on a year earlier; public on 6 May 2023
Quarter ended 1 Jul 2023: $10.7B, -2.6% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $10.6B, -1.0% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $10.9B, -4.9% on a year earlier; public on 23 Feb 2024
Quarter ended 30 Mar 2024: $10.3B, -3.4% on a year earlier; public on 4 May 2024
Quarter ended 29 Jun 2024: $10.5B, -1.4% on a year earlier; public on 3 Aug 2024
Quarter ended 28 Sep 2024: $10.6B, +0.2% on a year earlier; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $11.4B, +4.7% on a year earlier; public on 21 Feb 2025
Quarter ended 29 Mar 2025: $10.4B, +0.2% on a year earlier; public on 3 May 2025
Quarter ended 28 Jun 2025: $10.9B, +3.0% on a year earlier; public on 2 Aug 2025
Quarter ended 27 Sep 2025: $11.1B, +4.9% on a year earlier; public on 1 Nov 2025
Quarter ended 31 Dec 2025: $12.2B, +7.2% on a year earlier; public on 27 Feb 2026
Quarter ended 28 Mar 2026: $11.0B, +6.2% on a year earlier; public on 2 May 2026
Quarter ended 27 Jun 2026: $12.0B, +10% on a year earlier; public on 1 Aug 2026
Quarter ended 26 Sep 2026: $12.1B, +9.1% on a year earlier; public on 31 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $831.0M, +42% on a year earlier; public on 25 Feb 2022
Quarter ended 2 Apr 2022: $640.0M, +1.9% on a year earlier; public on 7 May 2022
Quarter ended 2 Jul 2022: $506.0M, -6.3% on a year earlier; public on 6 Aug 2022
Quarter ended 1 Oct 2022: $547.0M, +4.4% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $550.0M, -34% on a year earlier; public on 24 Feb 2023
Quarter ended 1 Apr 2023: $458.0M, -28% on a year earlier; public on 6 May 2023
Quarter ended 1 Jul 2023: $284.0M, -44% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $332.0M, -39% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $405.0M, -26% on a year earlier; public on 23 Feb 2024
Quarter ended 30 Mar 2024: $347.0M, -24% on a year earlier; public on 4 May 2024
Quarter ended 29 Jun 2024: $301.0M, +6.0% on a year earlier; public on 3 Aug 2024
Quarter ended 28 Sep 2024: $272.0M, -18% on a year earlier; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $480.0M, +19% on a year earlier; public on 21 Feb 2025
Quarter ended 29 Mar 2025: $362.0M, +4.3% on a year earlier; public on 3 May 2025
Quarter ended 28 Jun 2025: $294.0M, -2.3% on a year earlier; public on 2 Aug 2025
Quarter ended 27 Sep 2025: $404.0M, +49% on a year earlier; public on 1 Nov 2025
Quarter ended 31 Dec 2025: $465.0M, -3.1% on a year earlier; public on 27 Feb 2026
Quarter ended 28 Mar 2026: $376.0M, +3.9% on a year earlier; public on 2 May 2026
Quarter ended 27 Jun 2026: $450.0M, +53% on a year earlier; public on 1 Aug 2026
Quarter ended 26 Sep 2026: $437.0M, +8.2% on a year earlier; public on 31 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 2,055; public on 14 Feb 2022
31 Mar 2022 report: 2,148; public on 16 May 2022
30 Jun 2022 report: 2,118; public on 15 Aug 2022
30 Sep 2022 report: 2,071; public on 14 Nov 2022
31 Dec 2022 report: 2,158; public on 14 Feb 2023
31 Mar 2023 report: 2,219; public on 15 May 2023
30 Jun 2023 report: 2,195; public on 14 Aug 2023
30 Sep 2023 report: 2,189; public on 14 Nov 2023
31 Dec 2023 report: 2,296; public on 14 Feb 2024
31 Mar 2024 report: 2,390; public on 15 May 2024
30 Jun 2024 report: 2,392; public on 14 Aug 2024
30 Sep 2024 report: 2,427; public on 14 Nov 2024
31 Dec 2024 report: 2,457; public on 14 Feb 2025
31 Mar 2025 report: 2,450; public on 15 May 2025
30 Jun 2025 report: 2,346; public on 14 Aug 2025
30 Sep 2025 report: 2,391; public on 14 Nov 2025
31 Dec 2025 report: 2,584; public on 17 Feb 2026
31 Mar 2026 report: 2,523; public on 15 May 2026
30 Jun 2026 report: 2,570; public on 14 Aug 2026
30 Sep 2026 report: 2,772; public on 16 Nov 2026
Federal obligations
Month from 1 Apr 2022: $62K published
Month from 1 May 2022: $18K published
Month from 1 Jun 2022: $0 published
Month from 1 Jul 2022: $805K published
Month from 1 Aug 2022: $10.7M published
Month from 1 Sep 2022: $83.5M published
Month from 1 Oct 2022: $5.5M published
Month from 1 Nov 2022: $384K published
Month from 1 Dec 2022: -$150.7M published
Month from 1 Jan 2023: $23.5M published
Month from 1 Feb 2023: $297K published
Month from 1 Mar 2023: $493K published
Month from 1 Apr 2023: $2.2M published
Month from 1 May 2023: $10.2M published
Month from 1 Jun 2023: $1.7M published
Month from 1 Jul 2023: $23.6M published
Month from 1 Aug 2023: $4.2M published
Month from 1 Sep 2023: $11.6M published
Month from 1 Oct 2023: $132.3M published
Month from 1 Nov 2023: $2.0M published
Month from 1 Dec 2023: $20.3M published
Month from 1 Jan 2024: $1.1M published
Month from 1 Feb 2024: $1.0M published
Month from 1 Mar 2024: $120.1M published
Month from 1 Apr 2024: $25.0M published
Month from 1 May 2024: $6.2M published
Month from 1 Jun 2024: $4.9M published
Month from 1 Jul 2024: $10.6M published
Month from 1 Aug 2024: $10.7M published
Month from 1 Sep 2024: $17.0M published
Month from 1 Oct 2024: $12.2M published
Month from 1 Nov 2024: $13.1M published
Month from 1 Dec 2024: $15.7M published
Month from 1 Jan 2025: $4.5M published
Month from 1 Feb 2025: $1.7M published
Month from 1 Mar 2025: $3.2M published
Month from 1 Apr 2025: $1.3M published
Month from 1 May 2025: $9.1M published
Month from 1 Jun 2025: $10.0M published
Month from 1 Jul 2025: $15.9M published
Month from 1 Aug 2025: $23.9M published
Month from 1 Sep 2025: $3.9M published
Month from 1 Oct 2025: $4.6M published
Month from 1 Nov 2025: $17.1M published
Month from 1 Dec 2025: $8.7M published
Month from 1 Jan 2026: $4.0M published
Month from 1 Feb 2026: $707K published
Month from 1 Mar 2026: $3.6M published
Month from 1 Apr 2026: $4.1M published
Month from 1 May 2026: $5.4M published
Month from 1 Jun 2026: $21.3M published
Month from 1 Jul 2026: $2.6M published
Month from 1 Aug 2026: $11.0M published
Month from 1 Sep 2026: $25.8M published
Month from 1 Oct 2026: $15.5M published
Month from 1 Nov 2026: $2.0M published
Lobbying spend
Quarter from 1 Jan 2022: $330K published
Quarter from 1 Apr 2022: $740K published
Quarter from 1 Jul 2022: $580K published
Quarter from 1 Oct 2022: $870K published
Quarter from 1 Jan 2023: $450K published
Quarter from 1 Apr 2023: $1.1M published
Quarter from 1 Jul 2023: $460K published
Quarter from 1 Oct 2023: $250K published
Quarter from 1 Jan 2024: $290K published
Quarter from 1 Apr 2024: $950K published
Quarter from 1 Jul 2024: $300K published
Quarter from 1 Oct 2024: $310K published
Quarter from 1 Jan 2025: $390K published
Quarter from 1 Apr 2025: $1.4M published
Quarter from 1 Jul 2025: $400K published
Quarter from 1 Oct 2025: $430K published
Quarter from 1 Jan 2026: $470K published
Quarter from 1 Apr 2026: $710K published
Quarter from 1 Jul 2026: $280K published
Quarter from 1 Oct 2026: $550K published
Workers in WARN layoff notices
Month from 1 Apr 2023: 113 published
Month from 1 Nov 2024: 160 published
Month from 1 Feb 2025: 300 published
Month from 1 Jan 2026: 103 published
Month from 1 Aug 2026: 15 published
What is unusual now
Made public in the last 90 days: it saw 309 13F filers open a new position in the quarter ended 30 Sep 2026, 1.6× the same quarter last year; it also had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year. 5 sharp changes in all. Two or more unrelated kinds of activity agreed on 30 Sep 2026.
Many funds opening a new position: saw 309 13F filers open a new position in the quarter ended 30 Sep 2026, 1.6× the same quarter last year Public on 16 Nov 2026.
WARN layoff notice: filed a WARN layoff notice covering 15 workers within 30 days (Franklin, MA, MA) Public on 14 Aug 2026.
H-1B/E-3 applications change: had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year Public on 24 Sep 2026.
Latest records
The names and amounts behind the totals, newest first
3,263 open postings; careers site tracked since 21 Nov 2026. Most in Research & science 25%, Operations & administration 11%, Sales & business development 7%, Supply chain & procurement 6%.
Reported lobbying spend: $550K in Q3 2026, $280K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Oct 2025
Ended
Manatt, Phelps, And Phillipsfor Thermo Fisher Scientific
Faegre Drinker Biddle & Reath LLPfor Bluebird Strategies (On Behalf Of Thermo Fisher Scientific)
Asthma policies and diagnostic allergy test coverage; H.R. 2009 - Removing Barriers to Allergy Diagnostic Testing Act of 2019; S. 2246 - Allergy Testing Access Act of 2019Budget, Health issues
Two or more unrelated kinds of records unusual within 30 days
30 Sep 2026confirmed
Confirmed across sources Government contracts and Hiring
Thermo Fisher Scientific(TMO): had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year, while it won its first award from the National Aeronautics and Space Administration, a $1.7M contract, after 32 earlier federal awards from other agencies. Two unrelated kinds of activity within 11 days.
Hiring: H-1B/E-3 applications change, became public on 24 Sep 2026
Government contracts: First award from a new federal agency, became public on 30 Sep 2026
Government contracts: First award from a new federal agency, became public on 6 Oct 2026
Government contracts: First award from a new federal agency, became public on 6 Oct 2026
May 2026 against the 5 months before it.
this monthearliernormal: 52See the evidence (4 changes)
Hiring: H-1B/E-3 applications change became public on 24 Sep 2026
Thermo Fisher Scientific had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year.
This period
17 (May 2026)
Normal month (median of 5 earlier)
52
Typical spread (median absolute deviation)
6
How far from its usual level
-3.9
Same month last year
52
History used
2,434 days
May 20265 earlier monthsnormal: 52
Fires when the period is at least 3.5 robust standard deviations away from the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Government contracts: First award from a new federal agency became public on 6 Oct 2026
Thermo Fisher Scientific won its first award from the Department of Homeland Security, a $2.3M contract, after 32 earlier federal awards from other agencies.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Government contracts: First award from a new federal agency became public on 6 Oct 2026
Thermo Fisher Scientific won its first award from the National Aeronautics and Space Administration, a $1.7M contract, after 32 earlier federal awards from other agencies.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
17 Feb 2026confirmed
Confirmed across sources Attention and Institutional holdings and Layoff notices
Thermo Fisher Scientific(TMO): filed a WARN layoff notice covering 103 workers within 30 days (Franklin, MA, MA); it also saw 194 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year; and it drew 6,495 Wikipedia page views in the week of 9 Mar 2026, 1.4× the same week last year. Three unrelated kinds of activity within 52 days.
Layoff notices: WARN layoff notice, became public on 24 Jan 2026
Institutional holdings: Many funds opening a new position, became public on 17 Feb 2026
Attention: Wikipedia attention spike, became public on 17 Mar 2026
The quarter ended 31 Dec 2025 against the 8 quarters before it.
this quarterearliernormal: 125See the evidence (3 changes)
Layoff notices: WARN layoff notice became public on 24 Jan 2026
Thermo Fisher Scientific filed a WARN layoff notice covering 103 workers within 30 days (Franklin, MA, MA).
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Institutional holdings: Many funds opening a new position became public on 17 Feb 2026
Thermo Fisher Scientific saw 194 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.
This period
194 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
125
Typical spread (median absolute deviation)
10.5
How far from its usual level
+4.4
Same quarter last year
96
History used
4,475 days
the quarter ended 31 Dec 20258 earlier quartersnormal: 125
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Attention: Wikipedia attention spike became public on 17 Mar 2026
Thermo Fisher Scientific drew 6,495 Wikipedia page views in the week of 9 Mar 2026, 1.4× the same week last year.
This period
6,495 (the week of 9 Mar 2026)
Normal week (median of 26 earlier)
4,050
Typical spread (median absolute deviation)
224
How far from its usual level
+6.0
Same week last year
4,770
History used
2,630 days
the week of 9 Mar 202626 earlier weeksnormal: 4,050
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
12 Aug 2025confirmed
Confirmed across sources Government contracts and Lobbying
Thermo Fisher Scientific(TMO): reported $1.4M of lobbying spend for the quarter ended 31 Mar 2025, 1.5× the same quarter last year, while it booked $12.5M in federal contract and grant obligations in July 2025, 3.5% below the same month last year. Two unrelated kinds of activity within 30 days.
Lobbying: Lobbying spend jump, became public on 6 May 2025
Government contracts: Federal obligations jump, became public on 31 Jul 2025
Government contracts: First award from a new federal agency, became public on 22 Aug 2025
The quarter ended 31 Mar 2025 against the 8 quarters before it.
this quarterearliernormal: $350KSee the evidence (3 changes)
Lobbying: Lobbying spend jump became public on 6 May 2025
Thermo Fisher Scientific reported $1.4M of lobbying spend for the quarter ended 31 Mar 2025, 1.5× the same quarter last year.
This period
$1.4M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$350K
Typical spread (median absolute deviation)
$80K
How far from its usual level
+9.3
Same quarter last year
$950K
History used
5,934 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $350K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Government contracts: Federal obligations jump became public on 31 Jul 2025
Thermo Fisher Scientific booked $12.5M in federal contract and grant obligations in July 2025, 3.5% below the same month last year.
This period
$12.5M (July 2025)
Normal month (median of 5 earlier)
$27K
Typical spread (median absolute deviation)
$27K
How far from its usual level
+12.4
Same month last year
$12.9M
History used
6,491 days
July 20255 earlier monthsnormal: $27K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
16 Nov 2026Institutional holdings change
saw 309 13F filers open a new position in the quarter ended 30 Sep 2026, 1.6× the same quarter last year.
Same quarter last year: 195; its normal quarter is 132.
See the evidence
This period
309 (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
132
Typical spread (median absolute deviation)
27
How far from its usual level
+4.4
Same quarter last year
195
History used
4,748 days
the quarter ended 30 Sep 20268 earlier quartersnormal: 132
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year, while it won its first award from the National Aeronautics and Space Administration, a $1.7M contract, after 32 earlier federal awards from other agencies. Two unrelated kinds of activity within 11 days.
See the evidence (4 changes)
Hiring: H-1B/E-3 applications change became public on 24 Sep 2026
Thermo Fisher Scientific had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year.
This period
17 (May 2026)
Normal month (median of 5 earlier)
52
Typical spread (median absolute deviation)
6
How far from its usual level
-3.9
Same month last year
52
History used
2,434 days
May 20265 earlier monthsnormal: 52
Fires when the period is at least 3.5 robust standard deviations away from the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Government contracts: First award from a new federal agency became public on 6 Oct 2026
Thermo Fisher Scientific won its first award from the Department of Homeland Security, a $2.3M contract, after 32 earlier federal awards from other agencies.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Government contracts: First award from a new federal agency became public on 6 Oct 2026
Thermo Fisher Scientific won its first award from the National Aeronautics and Space Administration, a $1.7M contract, after 32 earlier federal awards from other agencies.
"First" means first in our data: it fires only when the source's history began at least 365 days earlier.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
30 Sep 2026Government contracts change
won its first award from the Department of Energy, a $1.3M contract, after 29 earlier federal awards from other agencies.
had 17 H-1B/E-3 visa applications certified in May 2026, 67% below the same month last year.
Same month last year: 52; its normal month is 52.
See the evidence
This period
17 (May 2026)
Normal month (median of 5 earlier)
52
Typical spread (median absolute deviation)
6
How far from its usual level
-3.9
Same month last year
52
History used
2,434 days
May 20265 earlier monthsnormal: 52
Fires when the period is at least 3.5 robust standard deviations away from the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.
drew 6,495 Wikipedia page views in the week of 9 Mar 2026, 1.4× the same week last year.
Same week last year: 4,770; its normal week is 4,050.
See the evidence
This period
6,495 (the week of 9 Mar 2026)
Normal week (median of 26 earlier)
4,050
Typical spread (median absolute deviation)
224
How far from its usual level
+6.0
Same week last year
4,770
History used
2,630 days
the week of 9 Mar 202626 earlier weeksnormal: 4,050
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
filed a WARN layoff notice covering 103 workers within 30 days (Franklin, MA, MA); it also saw 194 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year; and it drew 6,495 Wikipedia page views in the week of 9 Mar 2026, 1.4× the same week last year. Three unrelated kinds of activity within 52 days.
See the evidence (3 changes)
Layoff notices: WARN layoff notice became public on 24 Jan 2026
Thermo Fisher Scientific filed a WARN layoff notice covering 103 workers within 30 days (Franklin, MA, MA).
Fires on a WARN notice after 30 days without one; notices within 30 days are summed.
Institutional holdings: Many funds opening a new position became public on 17 Feb 2026
Thermo Fisher Scientific saw 194 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.
This period
194 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
125
Typical spread (median absolute deviation)
10.5
How far from its usual level
+4.4
Same quarter last year
96
History used
4,475 days
the quarter ended 31 Dec 20258 earlier quartersnormal: 125
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Attention: Wikipedia attention spike became public on 17 Mar 2026
Thermo Fisher Scientific drew 6,495 Wikipedia page views in the week of 9 Mar 2026, 1.4× the same week last year.
This period
6,495 (the week of 9 Mar 2026)
Normal week (median of 26 earlier)
4,050
Typical spread (median absolute deviation)
224
How far from its usual level
+6.0
Same week last year
4,770
History used
2,630 days
the week of 9 Mar 202626 earlier weeksnormal: 4,050
Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
17 Feb 2026Institutional holdings change
saw 194 13F filers open a new position in the quarter ended 31 Dec 2025, 2.0× the same quarter last year.
Same quarter last year: 96; its normal quarter is 125.
See the evidence
This period
194 (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
125
Typical spread (median absolute deviation)
10.5
How far from its usual level
+4.4
Same quarter last year
96
History used
4,475 days
the quarter ended 31 Dec 20258 earlier quartersnormal: 125
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 195 13F filers open a new position in the quarter ended 30 Sep 2025, 1.5× the same quarter last year.
Same quarter last year: 128; its normal quarter is 118.
See the evidence
This period
195 (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
118
Typical spread (median absolute deviation)
13
How far from its usual level
+4.0
Same quarter last year
128
History used
4,383 days
the quarter ended 30 Sep 20258 earlier quartersnormal: 118
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 183 entries; narrow the window or the kind of data to see older ones.
Not listed: 393 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000097745
Ticker
TMO
Domain
thermofisher.com
Employer name
NALGE NUNC INTERNATIONAL, Thermo Fisher Scientific (2 unverified)
Hq location
MA|WALTHAM|02451 (1 unverified)
Lobbying client
bluebird strategies on behalf of thermo fisher scientific, hamilton place strategies on behalf of thermo fisher scientific, health iq, thermo fisher scientific and 1 more
Name
0972792 B.C. LTD, 236 Perinton Parkway, LLC, 27 Forge Parkway LLC, Abgene Inc and 1139 more
Uei
GK3LCBGHLUK6, KVFLEJCUE8X9, N3TTP71B2SY9, NTK6QLWCHVH5 and 4 more
Wikidata
Q643674
Wikipedia
Thermo Fisher Scientific
DOL H-1B labor condition applications and PERM certifications1836 data points1 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)54 records, 246 data points30 Dec 1899 to 30 Sep 2026
SEC Form 13F institutional holdings17 records, 481 data points30 Jun 2013 to 16 Nov 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)192 records8 Jan 2016 to 30 Oct 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1247 data points31 Dec 2006 to 26 Sep 2026
SEC Form 4 insider transactions227 records, 760 data points19 Jan 2016 to 16 Nov 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards35 records, 3380 data points23 Oct 2007 to 20 Nov 2026
WARN layoff notices (state labor agencies)9 records, 18 data points26 Jan 2004 to 13 Aug 2026
Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026